drugset / Trial / NCT02259998
Pharmacokinetics of Two Different Persantin® Sugar Coated Tablets in Healthy Male Volunteers
RandomizedCrossoverOpen-labelTreatment
Summary
To investigate the relative bioavailability of the proposed formulation of PERSANTIN® compared to the present commercial formulation.
Timeline
- Start
- 2001-10
- Primary completion
- 2001-12
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Dipyridamole | Other / unclassified | 75 mg | Oral |
Indications
No indication recorded.